TAKING HOLD
CONQUERING
CANCER
Halda is developing RIPTAC therapeutics, a new class of precision medicines to defeat cancer.
TAKING HOLD
CONQUERING
CANCER
Halda is developing RIPTAC therapeutics, a new class of precision medicines to defeat cancer.
 
 

Doubling down
Against cancer
with a novel drug modality

 

Riptac therapeutics use a ‘hold-and-kill’ mechanism that is an innovative way to defeat cancer

Our RIPTAC therapeutics hold two proteins together: one that is tumor-specific and another that performs an essential function. The novel protein-protein interaction results in selective killing of the cancer cell.

 
 

Our team is a
collective force

for drug innovation to conquer cancer

 
 
 

Take hold of your future and explore careers at Halda

 
 
Back to Top